Home
Business
Tech
Education
Interviews and Features
Others
Books
CSR
Environment
Entertainment
Health and Wellness
Finance
Hospitality
International
Lifestyle
Sports
Startup
Travel
Search
Webnewswire
News for the people
Downtown
Magazine PRO
3.7
C
London
Saturday, December 28, 2024
Home
Refund Policy
Privacy Policy
Terms & Conditions
Submit Your Press Releases (Free)
Sponsored Posts
About
Facebook
Instagram
Twitter
Youtube
Webnewswire
News for the people
Home
Business
Tech
Education
Interviews and Features
Others
Books
CSR
Environment
Entertainment
Health and Wellness
Finance
Hospitality
International
Lifestyle
Sports
Startup
Travel
Search
Subscribe
Webnewswire
News for the people
Home
Business
Tech
Education
Interviews and Features
Others
Books
CSR
Environment
Entertainment
Health and Wellness
Finance
Hospitality
International
Lifestyle
Sports
Startup
Travel
Search
Subscribe
Home
Tags
Lenvima
Tag: Lenvima
Business
Japan – Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma
-
September 13, 2022
0
Business
LENVIMA in Combination with KEYTRUDA Approved In Taiwan for the Treatment of Patients with Advanced Endometrial Carcinoma
-
March 7, 2022
0
Uncategorized
Japan – Lenvima (Lenvatinib) Approved for Additional Indication of Unresectable Thymic Carcinoma in Japan
-
May 10, 2021
0